Theras

Theras Group is an Italian biomedical company founded in 2011 and headquartered in Salsomaggiore Terme, Parma, Italy. The company is dedicated to developing and promoting advanced technologies and services for the therapeutic management of chronic diseases, with particular focus on diabetes, chronic pain, and obesity. Theras Group operates through multiple divisions including Theras Lifetech, Theras Consumer Health, and Theras Biocare, offering comprehensive solutions for disease management and everyday health.

The company serves as the exclusive distributor in Italy for leading American medical technology companies such as Dexcom for continuous glucose monitoring systems, Insulet for the Omnipod insulin pump, and Nevro for chronic pain treatment therapies. Additionally, Theras distributes Plenity for weight management and maintains the historic Pic Solution consumer health brand following its acquisition. With approximately 80 employees and partnerships with over 100 hospitals and specialist clinics throughout Italy, Theras Group has experienced remarkable growth, achieving a 100% revenue increase from 32 million euros in 2018 to nearly 65 million euros in 2019. The company has been recognized among Europe's fastest-growing companies by the Financial Times and has received multiple awards for business excellence and financial reliability.